Yuhan Corporation

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Clinical Trial to Evaluate the Safety and Efficacy of NTCB01-1 in Patients Who Require Parenteral Nutrition

Phase 3

Not yet recruiting

Conditions: Parenteral Nutrition

Interventions: Drug: NTCB01-1
Drug: NTCB-P

First Posted Date: 2024-10-03

Last Posted Date: 2024-10-15

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 60

Registration Number: NCT06625931

Locations: 🇰🇷
Keimyung University Dongsan Hospital, Daegu, Dalseo-gu, Korea, Republic of
🇰🇷
Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Dongjak-gu, Korea, Republic of
🇰🇷
Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of

and more 4 locations

Clinical Trial to Evaluate the Safety and Efficacy of NTCB02-1 in Patients Who Require Parenteral Nutrition

Phase 3

Not yet recruiting

Conditions: Parenteral Nutrition

Interventions: Drug: NTCB02-1
Drug: NTCB-C

First Posted Date: 2024-10-03

Last Posted Date: 2024-10-03

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 60

Registration Number: NCT06625957

Clinical Trial to Evaluate the PK Interactions of YHR2402 Monotherapy and YHR2402 and YHR2403 Co-Administration in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: YHR2402
Drug: YHR2402+YHR2403

First Posted Date: 2024-10-02

Last Posted Date: 2024-11-22

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 26

Registration Number: NCT06623526

Locations: 🇰🇷
Jeonbuk National University Hospital, Jeonju, Korea, Republic of

A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

Phase 1

Recruiting

Conditions: NSCLC (Non-small Cell Lung Cancer)
Solid Tumor

Interventions: Drug: YH42946

First Posted Date: 2024-09-27

Last Posted Date: 2024-11-14

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 161

Registration Number: NCT06616766

Locations: 🇺🇸
Next Oncology Virginia, Fairfax, Virginia, United States
🇰🇷
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
🇰🇷
The Catholic Univ. of Korea St. Vincent's Hospital, Suwon-si, Gyeonggi-do, Korea, Republic of

and more 3 locations

Bioequivalence Study Between YHP2305 and YHR2404 in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: YHP2305
Drug: YHR2404

First Posted Date: 2024-09-25

Last Posted Date: 2024-11-15

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 34

Registration Number: NCT06613139

Locations: 🇰🇷
Bumin Hospital, Seoul, Korea, Republic of

A First-in-Human, Single- and Multiple-Ascending Dose Study of YH35995 in Healthy Adult Male Participants

Phase 1

Recruiting

Conditions: Healthy Participants

Interventions: Drug: YH35995
Drug: Placebo

First Posted Date: 2024-07-24

Last Posted Date: 2024-11-21

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 96

Registration Number: NCT06517914

Locations: 🇰🇷
CHA Bundang Medical Center, Seongnam, Bundang-gu, Korea, Republic of

Bioequivalence Study Between YHP2205 and YHR2401 in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: YHP2205
Drug: YHR2401

First Posted Date: 2024-04-11

Last Posted Date: 2024-11-12

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 60

Registration Number: NCT06359626

Locations: 🇰🇷
Bumin Hospital, Seoul, Korea, Republic of

Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia

Completed

Conditions: Hypertension
Hypercholesterolemia

Interventions: Drug: Rosuampin 5/5mg, 10/5mg, 20/5mg, 10/10mg

First Posted Date: 2024-03-05

Last Posted Date: 2024-11-21

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 5047

Registration Number: NCT06293261

Locations: 🇰🇷
Dong-A University Hospital, Busan, Korea, Republic of
🇰🇷
Gyeongsang National University Changwon Hospital, Changwon, Korea, Republic of
🇰🇷
Daegu Catholic University Medical Center, Daegu, Korea, Republic of

and more 36 locations

Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients with Essential Hypertension

Active, not recruiting

Conditions: Essential Hypertension

First Posted Date: 2024-02-28

Last Posted Date: 2024-11-19

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 1219

Registration Number: NCT06282549

Locations: 🇰🇷
Busan Veterans Hospital, Busan, Korea, Republic of
🇰🇷
Daegu Veterans Hospital, Daegu, Korea, Republic of
🇰🇷
Gwangju Veterans Hospital, Gwangju, Korea, Republic of

and more 2 locations

Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation

Active, not recruiting

Conditions: NSCLC

First Posted Date: 2024-02-07

Last Posted Date: 2024-12-06

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 2001

Registration Number: NCT06247280

Locations: 🇰🇷
Kyungpook National University Chilgok Hospital, Chilgok, Daegu, Korea, Republic of
🇰🇷
Wonju Severance Christian Hospital, Wonju, Gangwon-do, Korea, Republic of
🇰🇷
Hallym Univ. Medical Center. Chuncheon, Chuncheon, Gangwon, Korea, Republic of

and more 36 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy